7A5-32403-13905
1 vaccination
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 741 / OK
- Registered
- 2022-01-13
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-01-06
Dose 1 — Pfizer-BioNTech
-
2022-01-13
Registered in v-safe
-
2022-01-13
Survey response — day 7, dose 1MedDRA: Dyspnoea, Heart rate increased — Feeling: Fair · Site: Pain, Redness, Swelling · Headache · Be unable to do your normal daily activitiesFree text: Fast heart rate, shortness of breatheMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-06 | Pfizer-BioNTech | No |
Free text
Release 10 — day 7, dose 1
Systemic reaction (other): Fast heart rate, shortness of breathe
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release